Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Chemomab Therapeutics Ltd. buy krebskrebs

Chemomab Therapeutics Ltd.
Start price
€1.45
03.04.23 / 50%
Target price
€2.50
03.04.24
Performance (%)
-52.07%
End price
€0.70
04.04.24
Summary
This prediction ended on 04.04.24 with a price of €0.70. The BUY prediction by krebskrebs for Chemomab Therapeutics Ltd. performed very badly with a performance of -52.07%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Chemomab Therapeutics Ltd. - - -
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

Comments by krebskrebs for this prediction

In the thread Chemomab Therapeutics Ltd. diskutieren
Prediction Buy
Perf. (%) -52.07%
Target price 2.500
Change
Ends at

Buy mit Kursziel 2,5

krebskrebs 
0
Report Share
03.04.23
In the thread Trading Chemomab Therapeutics Ltd.
Prediction Buy
Perf. (%) -52.07%
Target price 2.500
Change
Ends at 03.04.24

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

krebskrebs 
0
Report Share
04.04.24